- Home
- ASTH vs LGND Comparison
ASTH vs LGND Comparison
Compare ASTH & LGND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASTH
- LGND
- Stock Information
- Founded
- ASTH 1994
- LGND 1987
- Country
- ASTH United States
- LGND United States
- Employees
- ASTH N/A
- LGND N/A
- Industry
- ASTH Professional Services
- LGND Biotechnology: Pharmaceutical Preparations
- Sector
- ASTH Consumer Discretionary
- LGND Health Care
- Exchange
- ASTH Nasdaq
- LGND Nasdaq
- Market Cap
- ASTH 1.7B
- LGND 2.0B
- IPO Year
- ASTH N/A
- LGND 1992
- Fundamental
- Price
- ASTH $25.28
- LGND $114.58
- Analyst Decision
- ASTH Strong Buy
- LGND Strong Buy
- Analyst Count
- ASTH 8
- LGND 8
- Target Price
- ASTH $53.29
- LGND $144.71
- AVG Volume (30 Days)
- ASTH 266.4K
- LGND 139.7K
- Earning Date
- ASTH 08-06-2025
- LGND 08-05-2025
- Dividend Yield
- ASTH N/A
- LGND N/A
- EPS Growth
- ASTH N/A
- LGND N/A
- EPS
- ASTH 0.73
- LGND N/A
- Revenue
- ASTH $2,250,574,000.00
- LGND $181,488,000.00
- Revenue This Year
- ASTH $34.97
- LGND $18.41
- Revenue Next Year
- ASTH $21.52
- LGND $18.87
- P/E Ratio
- ASTH $34.63
- LGND N/A
- Revenue Growth
- ASTH 54.81
- LGND 53.40
- 52 Week Low
- ASTH $23.12
- LGND $81.74
- 52 Week High
- ASTH $63.20
- LGND $129.90
- Technical
- Relative Strength Index (RSI)
- ASTH 47.92
- LGND 52.58
- Support Level
- ASTH $24.39
- LGND $111.72
- Resistance Level
- ASTH $25.96
- LGND $115.53
- Average True Range (ATR)
- ASTH 1.22
- LGND 3.23
- MACD
- ASTH 0.14
- LGND -0.44
- Stochastic Oscillator
- ASTH 50.00
- LGND 28.09
About ASTH Astrana Health Inc. Common Stock
Astrana Health Inc is a patient-centered, physician-centric integrated population health management company. The company is working to provide coordinated, outcomes-based medical care cost-effectively. It is focused on physicians providing high-quality medical care, population health management, and care coordination for patients, particularly senior patients and patients with multiple chronic conditions. Its operating segment is the healthcare delivery segment.
About LGND Ligand Pharmaceuticals Incorporated
Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.